• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用非酶法提高人胚胎干细胞的转染效率和代谢活性。

Improved Transfection Efficiency and Metabolic Activity in Human Embryonic Stem Cell Using Non-Enzymatic Method.

作者信息

Kim C-Yoon, Hwang In-Kyu, Kang Changhee, Chung Eun-Bin, Jung Cho-Rok, Oh Hanseul, Jeong Young-Hoon, Moon Sung-Hwan, Kim Jong Soo, Hong Ki-Sung, Park Jae-Hak, Chung Hyung-Min

机构信息

Department of Stem Cell Biology, School of Medicine, Konkuk University, Seoul, Korea.

Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University, Seoul, Korea.

出版信息

Int J Stem Cells. 2018 Nov 30;11(2):149-156. doi: 10.15283/ijsc18037.

DOI:10.15283/ijsc18037
PMID:30173502
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6285293/
Abstract

Human embryonic stem cells (hESCs) are pluripotent cells widely used in conventional and regenerative medicine due to their ability to self-renew, proliferate and differentiate. Recently, genetic modification of stem cells using genome editing is the most advanced technique for treating hereditary diseases. Nevertheless, the low transfection efficiency of hESCs using enzymatic methods is still limited in preclinical research. To overcome these limitations, we have developed transfection methods using non-enzymatic treatments on hESCs. In this study, hESCs were transfected following enzymatic (TrypLE and trypsin) and non-enzymatic treatment ethylenediaminetetraacetic acid (EDTA) to increase transfection efficiency. Flow cytometric analysis using an enhanced green fluorescent protein vector showed a significantly increased transfection efficiency of EDTA method compared to standard enzyme method. In addition, the EDTA approach maintained stable cell viability and recovery rate of hESCs after transfection. Also, metabolic activity by using Extracellular Flux Analyzer revealed that EDTA method maintained as similar levels of cell functionality as normal group comparing with enzymatic groups. These results suggest that transfection using EDTA is a more efficient and safe substitute for transfection than the use of standard enzymatic methods.

摘要

人胚胎干细胞(hESCs)是多能干细胞,因其自我更新、增殖和分化的能力而广泛应用于传统医学和再生医学。近来,利用基因组编辑对干细胞进行基因改造是治疗遗传性疾病的最先进技术。然而,在临床前研究中,使用酶法对hESCs进行转染的效率较低,仍然存在局限性。为克服这些局限性,我们开发了对hESCs采用非酶处理的转染方法。在本研究中,对hESCs进行酶处理(胰蛋白酶和胰蛋白酶)和非酶处理乙二胺四乙酸(EDTA)后进行转染,以提高转染效率。使用增强型绿色荧光蛋白载体进行的流式细胞术分析显示,与标准酶法相比,EDTA法的转染效率显著提高。此外,EDTA方法在转染后维持了hESCs稳定的细胞活力和回收率。而且,使用细胞外通量分析仪进行的代谢活性分析表明,与酶处理组相比,EDTA法维持的细胞功能水平与正常组相似。这些结果表明,与使用标准酶法相比,使用EDTA进行转染是一种更高效、更安全的转染替代方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df8/6285293/ef933e42962a/ijsc-11-149f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df8/6285293/2143744739ab/ijsc-11-149f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df8/6285293/c1d926785365/ijsc-11-149f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df8/6285293/ef933e42962a/ijsc-11-149f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df8/6285293/2143744739ab/ijsc-11-149f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df8/6285293/c1d926785365/ijsc-11-149f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df8/6285293/ef933e42962a/ijsc-11-149f3.jpg

相似文献

1
Improved Transfection Efficiency and Metabolic Activity in Human Embryonic Stem Cell Using Non-Enzymatic Method.使用非酶法提高人胚胎干细胞的转染效率和代谢活性。
Int J Stem Cells. 2018 Nov 30;11(2):149-156. doi: 10.15283/ijsc18037.
2
Gene Manipulation of Human Embryonic Stem Cells by In Vitro-Synthesized mRNA for Gene Therapy.体外合成 mRNA 对人类胚胎干细胞进行基因操作用于基因治疗。
Curr Gene Ther. 2015;15(4):428-35. doi: 10.2174/1566523215666150515144533.
3
Improving the Gene Transfection in Human Embryonic Stem Cells: Balancing with Cytotoxicity and Pluripotent Maintenance.提高人胚胎干细胞的基因转染效率:兼顾细胞毒性和多能性维持。
ACS Appl Mater Interfaces. 2016 Apr 6;8(13):8367-75. doi: 10.1021/acsami.6b00353. Epub 2016 Mar 23.
4
Enhanced Immunological Tolerance by HLA-G1 from Neural Progenitor Cells (NPCs) Derived from Human Embryonic Stem Cells (hESCs).源自人类胚胎干细胞(hESCs)的神经祖细胞(NPCs)中的HLA-G1增强免疫耐受性。
Cell Physiol Biochem. 2017;44(4):1435-1444. doi: 10.1159/000485539. Epub 2017 Nov 30.
5
Stably transfected human embryonic stem cell clones express OCT4-specific green fluorescent protein and maintain self-renewal and pluripotency.稳定转染的人胚胎干细胞克隆表达OCT4特异性绿色荧光蛋白,并维持自我更新和多能性。
Stem Cells. 2005;23(1):124-33. doi: 10.1634/stemcells.2004-0102.
6
Manipulation of OCT4 levels in human embryonic stem cells results in induction of differential cell types.对人类胚胎干细胞中OCT4水平进行调控会导致不同细胞类型的诱导产生。
Exp Biol Med (Maywood). 2007 Nov;232(10):1368-80. doi: 10.3181/0703-RM-63.
7
Nucleofection of human embryonic stem cells.人类胚胎干细胞的核转染
Methods Mol Biol. 2011;767:333-41. doi: 10.1007/978-1-61779-201-4_24.
8
Bone marrow mesenchymal stem cells: improving transgene expression level, transfection efficiency and cell viability.骨髓间充质干细胞:提高转基因表达水平、转染效率和细胞活力。
J BUON. 2018 Nov-Dec;23(6):1893-1903.
9
Lentiviral vector-mediated transgenesis in human embryonic stem cells.慢病毒载体介导的人类胚胎干细胞转基因技术
Methods Mol Biol. 2010;614:127-34. doi: 10.1007/978-1-60761-533-0_8.
10
Efficient Gene Editing in Pluripotent Stem Cells by Bacterial Injection of Transcription Activator-Like Effector Nuclease Proteins.通过细菌注射转录激活样效应核酸酶蛋白在多能干细胞中进行高效基因编辑
Stem Cells Transl Med. 2015 Aug;4(8):913-26. doi: 10.5966/sctm.2015-0030. Epub 2015 Jun 10.

引用本文的文献

1
PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia-reperfusion injury.过氧化物酶体增殖物激活受体β/δ 预激活增强间充质基质细胞在心肌缺血再灌注损伤中的抗凋亡和治疗作用。
Stem Cell Res Ther. 2022 Apr 23;13(1):167. doi: 10.1186/s13287-022-02840-0.
2
Matrix Production in Chondrocytes Transfected with Sex Determining Region Y-Box 9 and Telomerase Reverse Transcriptase Genes: An Evaluation from Monolayer Culture to Three-Dimensional Culture.转染性别决定区 Y 框 9 和端粒酶逆转录酶基因的软骨细胞中的基质产生:从单层培养到三维培养的评估。
Tissue Eng Regen Med. 2019 May 3;16(3):285-299. doi: 10.1007/s13770-019-00191-1. eCollection 2019 Jun.

本文引用的文献

1
Enzymatic passaging of human embryonic stem cells alters central carbon metabolism and glycan abundance.人胚胎干细胞的酶促传代改变了中心碳代谢和聚糖丰度。
Biotechnol J. 2015 Oct;10(10):1600-11. doi: 10.1002/biot.201400749. Epub 2015 Sep 10.
2
Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions.无酶消化法在化学成分确定的培养条件下传代和扩增人类多能干细胞。
Nat Protoc. 2012 Nov;7(11):2029-40. doi: 10.1038/nprot.2012.130. Epub 2012 Oct 25.
3
Chemically defined conditions for human iPSC derivation and culture.
人诱导多能干细胞的化学定义条件及其培养。
Nat Methods. 2011 May;8(5):424-9. doi: 10.1038/nmeth.1593. Epub 2011 Apr 10.
4
Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette.使用单可切除慢病毒干细胞盒生成无转基因肺疾病特异性人诱导多能干细胞。
Stem Cells. 2010 Oct;28(10):1728-40. doi: 10.1002/stem.495.
5
Enhanced transfection efficiency of human embryonic stem cells by the incorporation of DNA liposomes in extracellular matrix.通过将 DNA 脂质体掺入细胞外基质,提高人胚胎干细胞的转染效率。
Stem Cells Dev. 2010 Dec;19(12):1949-57. doi: 10.1089/scd.2009.0505. Epub 2010 Sep 29.
6
Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair.人胚干细胞源性 CD133+内皮祖细胞移植治疗性血管生成修复心肌。
Regen Med. 2010 Mar;5(2):231-44. doi: 10.2217/rme.09.83.
7
Combining angiogenic gene and stem cell therapies for myocardial infarction.联合血管生成基因与干细胞疗法治疗心肌梗死
J Gene Med. 2009 Sep;11(9):743-53. doi: 10.1002/jgm.1362.
8
Recurrent chromosomal abnormalities in human embryonic stem cells.人类胚胎干细胞中的复发性染色体异常。
Nat Biotechnol. 2008 Dec;26(12):1361-3. doi: 10.1038/nbt.1510. Epub 2008 Nov 23.
9
Feeder-free culture of human embryonic stem cells in conditioned medium for efficient genetic modification.在条件培养基中无饲养层培养人胚胎干细胞以实现高效基因修饰
Nat Protoc. 2008;3(9):1435-43. doi: 10.1038/nprot.2008.140.
10
Genetic modification of human embryonic stem cells for derivation of target cells.用于获取靶细胞的人类胚胎干细胞的基因改造。
Cell Stem Cell. 2008 May 8;2(5):422-33. doi: 10.1016/j.stem.2008.04.003.